Non-Interventional Study on Effectiveness of Elxaban Tab. in Patients With Non-valvular Atrial Fibrillation

Yonsei University

Status: Unknown

Conditions: Atrial Fibrillation

Study type: Observational

Funder types: Other

Identifiers

NCT04125641

4-2019-0536

Details and patient eligibility

About

This study is prospective Cohort study which was performed in multicenter (General Hospital) in Korea. Inclusion criteria is patients with atrial fibrillation taking Elxaban (generic drug of apixaban) who visit hospital. The purpose is to analyze bleeding (major bleeding, minor bleeding), stroke, systemic embolism, death, other clinical events (acute myocardial infarction, pulmonary embolism, transient ischemic attack, hospitalization), drug adherence, questionnaire of life quality (AFEQT), cognitive function (KDSQ) according to the use of Elxaban.

Enrollment: 5,000 estimated patients

Sex: All

Ages: 20+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. patients with atrial fibrillation taking Elxaban (patients with age more than 19)
2. Patients who agree with study inclusion

Exclusion criteria

1. patients who do not agree with study inclusion
2. patients with age less than 19
3. Pregnancy, Breastfeeding

Trial design

5,000 participants in 1 patient group

Elxaban group

Description:

AF patients taking Elxaban